Forecyte Bio Limited is a Contract Development and Manufacturing Organization (CDMO) established to meet the needs of the rapidly expanding Cell and Gene Therapy (CGT) industry. Built on decades of experience and expertise from its core technical experts in CGT Chemistry, Manufacturing, and Controls (CMC) processes, Forecyte Bio specializes in providing integrated solutions tailored to the unique requirements of clients in the pharmaceutical sector.

Services include:
- Cell line development
- Process development
- Analytical development
- Quality control testing
- Manufacturing support
- Regulatory support

Forecyte Bio Limited is committed to delivering high-quality services aimed at accelerating the development of innovative therapies. For more information, please visit forecytebio.com.